Flagyl and Rash erythematous aggravated - a phase IV clinical study of FDA data
Rash erythematous aggravated is found among people who take Flagyl, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Flagyl and have Rash erythematous aggravated. It is created by eHealthMe based on reports of 21,724 people who have side effects when taking Flagyl from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
21,724 people reported to have side effects when taking Flagyl.
Among them, 124 people (0.57%) have Rash erythematous aggravated.
What is Flagyl?
Flagyl has active ingredients of metronidazole. It is often used in vaginitis bacterial. eHealthMe is studying from 22,848 Flagyl users for its effectiveness, alternative drugs and more.
What is Rash erythematous aggravated?
Rash erythematous aggravated (worse redness of the skin) is found to be associated with 530 drugs and 256 conditions by eHealthMe.
Number of Flagyl and Rash erythematous aggravated reports submitted per year:
Time on Flagyl when people have Rash erythematous aggravated *:
Gender of people who have Rash erythematous aggravated when taking Flagyl*:
Age of people who have Rash erythematous aggravated when taking Flagyl *:
Common drugs people take besides Flagyl *:
Common side effects people have besides Rash erythematous aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Flagyl and have Rash erythematous aggravated?Check whether Rash erythematous aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Flagyl:
- Flagyl (22,848 reports)
Rash erythematous aggravated treatments and more:
- Rash erythematous aggravated (32 reports)
COVID vaccines that are related to Rash erythematous aggravated:
- Rash erythematous aggravated in Moderna COVID Vaccine
- Rash erythematous aggravated in Pfizer BioNTech Covid Vaccine
- Rash erythematous aggravated in Johnson and Johnson Covid Vaccine
How severe was Rash erythematous aggravated and when was it recovered:
Expand to all the drugs that have ingredients of metronidazole:
Common drugs associated with Rash erythematous aggravated:
All the drugs that are associated with Rash erythematous aggravated:
- Rash erythematous aggravated (530 drugs)
Common conditions associated with Rash erythematous aggravated:
All the conditions that are associated with Rash erythematous aggravated:
- Rash erythematous aggravated (256 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on metronidazole (the active ingredients of Flagyl) and Flagyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Adriamycin Pfs and Progesterone Receptor Assay Positive - 4 seconds ago
- Solu-Cortef and Acinetobacter Infection - 5 seconds ago
- Plendil and Bextra drug interaction - 6 seconds ago
- Fioricet and Propacet 100 drug interaction - 16 seconds ago
- Zometa and Diffuse Alveolar Damage - 27 seconds ago